Evolution of genetic markers for drug resistance after the introduction of dihydroartemisinin–piperaquine as first-line anti-malarial treatment for uncomplicated falciparum malaria in Indonesia

<strong>Background<br></strong> Dihydroartemisinin–piperaquine has been Indonesia’s first-line anti-malarial treatment since 2008. Annual therapeutic efficacy studies (TES) done in the last 12 years showed continued high treatment efficacy in uncomplicated Plasmodium falciparum mal...

Mô tả đầy đủ

Chi tiết về thư mục
Những tác giả chính: Rahmasari, FV, Asih, PBS, Rozi, IE, Wangsamuda, S, Risandi, R, Dewayanti, FK, Permana, DH, Syahrani, L, Prameswari, HD, Basri, HH, Bustos, MDG, Charunwatthana, P, Dondorp, AM, Imwong, M, Syafruddin, D
Định dạng: Journal article
Ngôn ngữ:English
Được phát hành: BioMed Central 2023

Những quyển sách tương tự